Return on Invested Capital (ROIC): 14.36%
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 14.36% is 51% below its 5-year average of 29.14%, near the low end of its 5-year range (14.36%–35.92%).
As of Saturday, June 27, 2026. 29.10% below its 12-month average of 20.25%.
NRC Return on Invested Capital (ROIC) Chart
Annual fiscal-year return on invested capital; no daily interpolation.
NRC Average Return on Invested Capital (ROIC) Chart
NRC Current vs Average Return on Invested Capital (ROIC) Chart
NRC Return on Invested Capital (ROIC) Metrics
RETURN ON INVESTED CAPITAL (ROIC)
14.36%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
20.25%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
26.82%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
29.14%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
30.17%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
25.90%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
23.10%
CURRENT VS TTM AVG
-29.10%
CURRENT VS 3Y AVG
-46.46%
CURRENT VS 5Y AVG
-50.72%
CURRENT VS 10Y AVG
-52.40%
CURRENT VS 15Y AVG
-44.56%
CURRENT VS 20Y AVG
-37.84%
NRC Competitors' Return on Invested Capital (ROIC)
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| National Research Corporation (NRC) | $468.99M | 14.36% | 20.25% | 26.82% | 29.14% |
| Shoulder Innovations, Inc. (SI)vs › | $472.62M | -14.80% | -28.02% | -25.91% | -25.91% |
| 23andMe Holding Co. (ME)vs › | $15.31M | -553.10% | -332.89% | -182.55% | -143.76% |
| Teladoc Health, Inc. (TDOC)vs › | $1.51B | -8.26% | -20.40% | -90.85% | -61.23% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.21B | 5.67% | -6.15% | -6.50% | -3.41% |
| TransMedics Group, Inc. (TMDX)vs › | $2.37B | 10.94% | 7.96% | -0.14% | -9.11% |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.57B | 6.02% | 9.35% | -2.77% | -9.72% |
| Oscar Health, Inc. (OSCR)vs › | $7.72B | -27.10% | -12.21% | -19.73% | -18.73% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.13B | 2.04% | 2.21% | 2.35% | 2.39% |
| Universal Health Services, Inc. (UHS)vs › | $9.12B | 11.29% | 10.92% | 8.93% | 9.01% |
Capital Efficiency
ROIC
14.4%
ROE
66.9%
Return on Invested Capital (ROIC) Formula & Definition
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Return on Invested Capital (ROIC) FAQ
- What is the return on invested capital (ROIC) for National Research Corporation (NRC)?
- The return on invested capital (ROIC) for NRC stock is 14.36%.
- Is National Research Corporation's return on invested capital (ROIC) high or low?
- The return on invested capital (ROIC) of 14.36% is 51% below its 5-year average of 29.14%, near the low end of its 5-year range (14.36%–35.92%).
- What is the TTM average return on invested capital (ROIC) for National Research Corporation (NRC)?
- The TTM average return on invested capital (ROIC) for NRC stock is 20.25%.
- What is the 3Y average return on invested capital (ROIC) for National Research Corporation (NRC)?
- The 3Y average return on invested capital (ROIC) for NRC stock is 26.82%.
- What is the 5Y average return on invested capital (ROIC) for National Research Corporation (NRC)?
- The 5Y average return on invested capital (ROIC) for NRC stock is 29.14%.
- What is the 10Y average return on invested capital (ROIC) for National Research Corporation (NRC)?
- The 10Y average return on invested capital (ROIC) for NRC stock is 30.17%.
- What is the 15Y average return on invested capital (ROIC) for National Research Corporation (NRC)?
- The 15Y average return on invested capital (ROIC) for NRC stock is 25.90%.
- What is the 20Y average return on invested capital (ROIC) for National Research Corporation (NRC)?
- The 20Y average return on invested capital (ROIC) for NRC stock is 23.10%.
NRC Return on Invested Capital (ROIC) History
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 14.36% |
| 2024-12-31 | 26.15% |
| 2023-12-31 | 33.00% |
| 2022-12-31 | 33.77% |
| 2021-12-31 | 31.65% |
| 2020-12-31 | 35.92% |
| 2019-12-31 | 44.32% |
| 2018-12-31 | 47.13% |
| 2017-12-31 | 23.82% |
| 2016-12-31 | 22.22% |
| 2015-12-31 | 19.48% |
| 2014-12-31 | 17.57% |
| 2013-12-31 | 17.49% |
| 2012-12-31 | 19.95% |
| 2011-12-31 | 15.25% |
| 2010-12-31 | 12.38% |
| 2009-12-31 | 15.72% |
| 2008-12-31 | 13.76% |
| 2007-12-31 | 14.57% |
| 2006-12-31 | 12.23% |
| 2005-12-31 | 14.38% |
| 2004-12-31 | 10.99% |
| 2003-12-31 | 11.23% |
| 2002-12-31 | 11.82% |
| 2001-12-31 | 5.98% |
| 2000-12-31 | 8.72% |
| 1999-12-31 | 6.42% |
| 1998-12-31 | 10.76% |
| 1997-12-31 | 23.67% |
| 1996-12-31 | 90.79% |
Related Metrics
About National Research Corporation
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Trent Green